Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. (2020)

First Author: Tsourdi E
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1210/clinem/dgaa756

PubMed Identifier: 33103722

Publication URI: http://europepmc.org/abstract/MED/33103722

Type: Journal Article/Review

Parent Publication: The Journal of clinical endocrinology and metabolism

ISSN: 0021-972X